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Abstract
 Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease 
involving several protein mutations in glycine-rich regions with limited treatment 
options. 90 - 95% of all cases are non-familial with epidemiological studies show-
ing a significant increased risk in glyphosate-exposed workers. In this paper, we 
propose that glyphosate, the active ingredient in Roundup®, plays a role in ALS, 
mainly through mistakenly substituting for glycine during protein synthesis, disrup-
tion of mineral homeostasis as well as setting up a state of dysbiosis. Mouse models 
of ALS reveal a pre-symptomatic profile of gut dysbiosis. This dysbiotic state ini-
tiate a cascade of events initially impairing metabolism in the gut, and, ultimately, 
through a series of intermediate stages, leading to motor neuron axonal damage 
seen in ALS. Lipopolysaccharide, a toxic by-product of dysbiosis which contrib-
utes to the pathology, is shown to be statistically higher in ALS patients. In this 
paper we paint a compelling view of how glyphosate exerts its deleterious effects, 
including mitochondrial stress and oxidative damage through glycine substitution. 
Furthermore, its mineral chelation properties disrupt manganese, copper and zinc 
balance, and it induces glutamate toxicity in the synapse, which results in a die-back 
phenomenon in axons of motor neurons supplying the damaged skeletal muscles.
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Introduction
 Amyotrophic Lateral Sclerosis (ALS) is a fatal neuro-
degenerative disease characterized by a progressive loss of mo-
tor neurons along with muscle atrophy. ALS is an adult onset 
disease, usually manifested first by weakness in the arms or legs 
and proceeding on to paralysis and death due to respiratory fail-
ure, often within five years of diagnosis[1,2]. The lifetime risk is 
between 1 in 400 and 1 in 1000, making it the most common 
motor neuron disease[3-5]. As of now there is no known treatment 
or cure. Recent evidence points to an important role in gut dys-
biosis in early stages of the disease. A seminal paper by Wu et 
al., published in 2015, examined alterations in gut microbes and 
associated metabolites in a mouse model for ALS, specifically 
targeting disruptions that preceded the onset of disease mani-
festations[6]. This ALS mouse model involves the expression 
of a mutant form of human superoxide dismutase 1 (SOD1), 
where glycine at residue 93 is replaced with alanine. The study 
revealed that young mice expressing human G93A SOD1 ex-
hibited damaged tight junction structure and increased gut per-
meability. This was associated with reduced expression of tight 
junction proteins Zonulin occludens-1 and E-cadherin, leading 
to impaired gut barrier function. Paneth cells were also abnor-
mal, with decreased expression of the antimicrobial peptide de-
fensin 5 alpha. Reduced levels of butyrate-producing intestinal 
microbes such as Butyrivibrio fibrisolvens and Fermicus and in-
creased expression of the inflammatory cytokine IL-17, as well 
as reduced levels of autophagic lysozyme 1 (leading to a reduced 
ability to clear misfolded proteins) were further markers of a 
disrupted microbiome. All of these features appeared when the 
mice were only 2 months old, before any symptoms of ALS had 
yet developed.
       Only about 5 - 10 % of the cases of ALS can be linked to 
known genetic defects (familial cases); the rest are idiopathic or 
sporadic (sALS). About 20 % of the familial cases are linked to 
mutations in SOD1[7]. There is a striking pathological and clin-
ical similarity between familial and idiopathic disease, leading 
researchers to believe that the mouse SOD1 model may be rep-
resentative of the sporadic cases as well as the familial ones. 
SOD1’s main function is to convert superoxide, produced as a 
toxic by-product of mitochondrial oxidative phosphorylation, 
to water or hydrogen peroxide. The deleterious effect of mu-
tant SOD1 however is not due to a loss of this function; most 
mutant forms exhibit full activity or even enhanced activity 
levels[3]. While there are more than 180 identified mutations of 
SOD1 in humans, three have been extensively characterized in 
transgenic mouse models, all of which involve substitutions for 
a conserved glycine residue in the original protein (SOD1G85R, 
SOD1G37R, and SOD1G93A). Often the mutant protein is 
expressed in the mouse genome at levels that are several-fold 
higher than the levels of endogenous SOD1[8]. Substitution of 
arginine for a highly conserved glycine (G10R) in a patient with 
fALS strongly destabilized the protein secondary structure, lead-
ing to intracellular aggregates[9].
           Impaired mitochondrial function has been linked to ALS, 
particularly related to Cytochrome c Oxidase (CcO)[10,11], and 
mutant SOD1 has been shown to suppress CcO activity[12]. In-
triguingly, both CcO and SOD1 depend on copper as a catalyst. 
Studies on G93A-SOD1 mice showed that the mutant mice ex-
hibited a decrease in mitochondrial respiration specific to com-
plex IV, and this defect was tied to impaired cytochrome c oxida-
tion, and occurred long before any overt symptoms appeared[13]. 
The amount of CcO on the inner mitochondrial membrane was 
reduced, and this was correlated with increased peroxidation of 
lipids, including cardiolipin. One explanation is that over ex-
pression of mutant SOD1 led to a decrease in the bioavailability 
of copper to CcO, leading to both impaired complex IV oxida-
tive phosphorylation and the excessive expression of reactive 
oxygen species. Another proposed theory is that mutant SOD1 
induces conformational changes that facilitate the interactions 
of catalytic copper with peroxynitrite or hydrogen peroxide to 
generate toxic free radicals which then damage cellular proteins 
and lipids[12].
         Remarkably, a variant of SOD1 that lacks all crucial resi-
dues needed for coordinate binding of Cu induces an ALS-like 
disease in mice that is indistinguishable from the disease pheno-
types of mice expressing other human SOD1 mutant forms[14]. 
The disease manifestation appears as the accumulation of mis-
folded high-molecular-weight SOD1 aggregates. This feature 
is also observed in the glycine-substituted mouse models. This 
suggests that a copper deficiency or impairment in copper bind-
ing may be a factor in the disease process, leading to oxidative 
and nitrosative stress due to free copper along with misfolded 
copper-deprived versions of both SOD1 and CcO.
       A study by Beckman et al. examined mice that over ex-
pressed both human SOD and human copper chaperone for su-
peroxide dismutase (CCS)[15]. These mice die of ALS at an ac-
celerated pace, probably because CCS sequestered the mouse’s 
supply of copper, inducing copper deficiency in the spinal cord. 
The depletion of copper affected both SOD1 and CcO function. 
A study from 2016 shows almost conclusively that impaired 
copper supply to SOD1 and to CcO is a strong factor in the dis-
ease[16]. These authors showed that a copper chelator, CuATSM, 
dissolved in dimethyl sulfoxide and dribbled onto the pup’s 
neck, was absorbed into the skin and became a bioavailable sup-
ply of copper to the central nervous system. This treatment had 
an effect within a few hours to significantly increase mobility 
in diseased mice, who suffered from both a SOD1 mutation and 
excessive expression of CCS. The general model that is emerg-
ing is that mutant SOD1 induces both protein misfolding and 
oxidative stress perhaps mediated by free copper that leads to 
mitochondrial dysfunction, along with impaired transport along 
axons leading to neuroinflammation and apoptosis of motor neu-
rons[17].
        The accumulation of misfolded proteins in ALS is not 
limited to SOD1. Two nuclear RNA/DNA binding proteins, 
TAR (transactive response) DNA-binding protein 43 (TDP-43) 
and FUsed in Sarcoma (FUS), are both found to be genetically 
linked to ALS[18]. TDP-43 is nearly always found in aggregates 
with ubiquitin in ALS  inclusions, both familial and sporadic[3,19]. 
In fact, remarkably, it has been found that pathological forms 
of TDP-43 or FUS can seed cytotoxic misfolding of endoge-
nous wild-type superoxide dismutase in a prion-like fashion[18]. 
These inclusion bodies induce an immune-inflammatory reac-
tion providing further damage to mitochondria and other cellu-
lar processes. The fact that ubiquitin positive cellular inclusions 
accumulate in motor neurons in association with ALS suggests 
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an impaired Ubiquitin-Proteasome System[20].
          In this paper, we make use of a deep and broad search of the 
research literature to find papers related to four distinct topics: 
(1) The disease mechanism of ALS, (2) The metabolic pathways 
involved in the synthesis of glycosaminoglycans in the extracel-
lular matrix and in glycoproteins, (3) epidemiological evidence 
of glyphosate as a causal factor in ALS as well as papers related 
to glyphosate’s mechanisms of toxicity, and (4) the many roles 
of glycine in proteins related to all of the above. We were moti-
vated initially by the new paper by Wu et al.[6] showing the early 
involvement of gut dysbiosis in the disease process in a mouse 
model of ALS.
         Our initial step was to enumerate most of the proteins 
which have genetic variants linked to ALS, and to specifically 
look for substitutions for glycine or mutations within glycine 
rich regions in these proteins in association with ALS. We were 
particularly struck by the association of fucose-depleted immu-
noglobulins with ALS, and this led to a thorough search for pa-
pers detailing all the enzymes and metabolic pathways involved 
in fucose synthesis, transport, and attachment to glycoproteins. 
We also explored the role of mineral imbalances in ALS, and the 
complex metabolic pathways related to fructose, a precursor to 
fucose. The novelty of our methods is the integration of research 
literature from diverse domains into a common story line, with 
particular emphasis on the presymptomatic stages of ALS.
       In the remainder of this paper, we will fill in the gaps 
in the story of how ALS develops, showing how gut dysbiosis 
can eventually lead to motor neuron deterioration, with several 
intervening steps. Beginning with the disruption of the gut mi-
crobiome well in advance of overt symptoms of ALS, the pathol-
ogy extends to metabolic disorders, particularly impairments in 
fructose metabolism, followed by steatosis, damage to skeletal 
muscle cells, and finally, the deterioration of the motor neurons 
in the spinal column. We will describe this entire cascade in the 
context of a theory that glyphosate, the active ingredient in the 
pervasive herbicide, Roundup®, can cause many of the impair-
ments that are observed in association with ALS. Much of this 
disruption can be attributed to glyphosate’s ability to substitute 
for glycine during protein synthesis, acting as a glycine ana-
logue[21]. Glyphosate’s disruption of mineral homeostasis likely 
also plays a role, particularly for manganese, copper and zinc[22-
25].
Glyphosate acting as a Glycine Analogue
 Glyphosate formulations are used extensively to con-
trol weeds growing among core crops in the processed food 
industry, particularly crops such as corn, soy, canola and sugar 
beets that are genetically engineered to be glyphosate tolerant. 
In the United States, usage of glyphosate has increased dramati-
cally (100-fold) over the past two decades, in step with the wide 
spread appearance of glyphosate resistance among weeds[26,27]. 
While glyphosate is generally believed to be nearly nontoxic to 
humans, the World Health Organization’s IARC labelled glypho-
sate as a “probable carcinogen” in 2015[28]. Reliable tests have 
confirmed that humans are exposed to glyphosate. Krüger et al. 
measured levels of glyphosate in urine samples from several 
hundred humans, and found statistically significantly higher lev-
els in those who were consuming a conventional diet compared 
to those consuming predominantly organic food (p < 0.0002)
[29]. Furthermore, chronically ill people had significantly higher 
levels than people who were healthy (p < 0.03). 
        Recent evidence suggests that glyphosate has insidious toxic 
effects that are mediated in part by an impaired microbiome[27,30]. 
The key disrupted pathway in plants, the shikimate pathway, is 
also found in many of the gut microbes, and this pathway sup-
plies essential aromatic amino acids and other nutrients to the 
host. Blockage in this pathway leads to an imbalance in gut mi-
crobes and disruption of fructose metabolism. As we will show 
here, this predicts profound effects on human physiology.
       A more disturbing feature of glyphosate stems from its 
serving as an amino acid analogue of glycine. In Samsel and 
Seneff[21], it was proposed that glyphosate is able to substitute 
for glycine during protein synthesis by mistake. In fact, this is 
probably the way it works to disrupt EPSPS in the shikimate 
pathway. A strong case was made based in part on evidence of 
a precedent with other natural amino acid analogues that are 
produced by organisms during stress conditions. In fact, one 
of these, the non-coding amino acid β-methylamino-L-alanine 
(BMAA), produced by cyanobacteria, incorporates into proteins 
in place of L-serine, causing an ALS-like condition[31,32]. An epi-
demic of ALS in Guam is attributed to BMAA contamination in 
the seeds of cycad trees[31] and an extremely high rate of ALS in 
the Kii Peninsula, Japan, appears to have a similar etiology[32]. 
BMAA synthesized by cyanobacteria residing in the intestinal 
microflora has been implicated in ALS and Parkinson’s-Demen-
tia complex as well as in equine motor neuron disease[33].
          The rhizosphere is a term used to describe that area of soil 
involving the roots of plants and most notably the absorption of 
nutrients[34]. Interestingly, a study examining changes in bacteri-
al gene expression in the rhizosphere following glyphosate treat-
ment showed striking upregulation in proteins involved in both 
protein biosynthesis and protein degradation[35]. This suggests 
that glyphosate caused protein misfolding and induced energy 
wasting through repeated cycles of synthesis and disassembly of 
misfolded proteins.
           Swanson et al.[36] have shown that many debilitating dis-
eases are increasing alarmingly in the United States, in step with 
the dramatic rise in glyphosate usage on core crops. In Samsel 
and Seneff[21], it was shown how many of the diseases identified 
in the Swanson et al. paper can be explained through glypho-
sate substitution for glycine in specific proteins where glycine is 
highly conserved and plays an important functional role.
          We hypothesize that the pathology leading to ALS begins 
slowly, but accelerates once liver function and the gut epithelial 
barrier have become severely compromised. Impaired gut bar-
rier function allows glyphosate to reach the general circulation. 
Excess fructose may accumulate owing to impairments in fruc-
tose metabolism in the gut. The liver’s inability to clear fruc-
tose then stresses muscle cells, particularly under conditions of 
high physical activity and minimal adipose tissue. High protein 
turnover and accumulation of glyphosate embedded proteins in 
the muscles that cannot be cleared by the proteasome eventually 
leads to autoimmune reactions to proteins involved in muscle 
signaling. This in turn stresses the motor neurons that synapse 
with the diseased skeletal muscles. A die-back beginning from 
axon terminals eventually leads to cellular apoptosis of the con-
trolling motor neuron, often associated with further development 
of autoimmune targeting of motor neuron proteins.
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4Evidence of a Link between Pesticides and ALS
 While we suspect that the food is the most important 
source of glyphosate exposure in the general population, an agri-
cultural worker is at much greater risk to occupational glyphosate 
exposure. While it is hard to obtain specific data on glyphosate, 
both pesticide exposure (OR = 1.44) and farming occupation 
(OR = 1.42) showed increased risk to ALS in a Korean study 
from 2014[37]. A survey in Michigan of 150 patients diagnosed 
with ALS found a much stronger link. Cumulative pesticide ex-
posure was highly significantly associated with ALS (OR = 5.09, 
p = 0.002)[38]. It is likely that glyphosate was used at much higher 
levels in Michigan compared to Korea due to the heavy produc-
tion of genetically engineered Roundup Ready soy in Michigan. 
Soybeans were Michigan’s largest export commodity in 2012, 
valued at over $800 million. A study based in Australia found an 
OR of 5.58 for exposure to industrial herbicides and pesticides, 
with a dose-response relationship[39]. A study based in Brittany 
obtained an odds ratio of 2.919 (p = 0.01) for an association be-
tween “agricultural activity” and ALS, and bulbar forms of the 
disease prevailed among those involved in agriculture[40].
            Glyphosate has recently been shown to pass easily across 
epithelial mucosal barriers in the nasal cavity, via active trans-
port by L-type amino acid transporters[41]. These authors wrote, 
“This additional pathway for glyphosate to enter the brain may 
result in much higher brain concentrations than previously an-
ticipated based on oral or intravenous exposures, and may also 
explain the occurrence of reported neurologic toxicities.”
         Resistance exercise increases the expression of amino acid 
transporters in muscle cells, including L-type amino acids (p < 
0.05)[42]. This is expected as exercise increases muscle turnover 
and therefore requires protein synthesis. But this implies that a 
person who is athletic and physically fit is more likely to ac-
cumulate glyphosate in the muscle cells via transport through 
the L-type amino acid transporters, and it might help explain 
the observed increased risk to ALS among the physically fit[43,44]. 
Glyphosate residues have been detected in the muscles of chick-
ens[45] and cows[29].
Table 1: Several proteins whose dysfunction is implicated in Amyo-
trophic Lateral Sclerosis and which have highly conserved essential 
glycines.
Protein Glycine Residue(s) Reference(s)
SOD1 G10, G37, G85, G93 C Ricci et al. 2010[9]
L Bruijn et al. 1996[8]
TDP-43 C-terminal gly-cine-rich region GS Pesiridis et al. 2009
[63]
FUS
glycine-rich region 
critical for RNA 
binding
SK Dhar et al. 2014[61] 
SLC351 G180, G198, G277 P. Zhang et al. 2012[80]
Complex I Gx(x)GxxG motif ME Baker et al.[66]
CcO G283 L Salomonsson et al. 2004[87]
ubiquitin C-terminal dou-ble-glycine A Zuin et al. 2014
[46]
myosin G699 NM. Kinose et al.,1996[175]
kinesin G292 BJ Grant et al., 2007[176]
Roles of Conserved Glycines in ALS related Proteins
 We noted previously that multiple glycine substitu-
tions within SOD1 can produce an ALS mouse model. In fact, 
we have identified several proteins, in addition to SOD1, with 
highly conserved glycines that are implicated in the pathology of 
ALS, as shown in Table 1. Most intriguing is the fact that ubiq-
uitin itself depends critically on a highly conserved carboxy ter-
minal double-glycine pair to build the complex ubiquitin chains 
that signal a protein for degradation[46]. Substitution of glypho-
sate for either of these essential glycines would be expected to 
impair the process of recycling misfolded proteins. This could 
readily explain the accumulation of misfolded proteins that is a 
hallmark feature of ALS.
          Protein aggregation of multiple proteins has been linked 
to ALS, including SOD1, TDP-43 and FUS. All three of these 
contain highly conserved glycines, and many of the ALS linked 
mutations are focused in glycine-rich regions[47,48], and often in-
volve substitutions of other amino acids for highly conserved 
glycines. This implies that these glycines are protective against 
ALS, possibly through protection from protein misfolding.
         Acylphosphatase is a small enzyme in which a large fraction 
of glycine residues are highly conserved across three domains 
of life[49]. An experiment involving systematically substituting 
six different glycine residues in human muscle acylphosphatase 
with other amino acids revealed that only G15A substitution 
causes a dramatic reduction in enzyme activity.
         However, all other substitutions tested resulted in a marked 
increase in the protein’s tendency to aggregate. The authors 
concluded that the likely reason why these other glycines were 
highly conserved was to protect from protein aggregation. Gly-
cine residues, due to the lack of a side chain, can occupy wider 
regions of conformational space. This leads to a substantial en-
tropic penalty when a glycine residue converts from a disordered 
structure into a β strand, an important step towards aggregation. 
Substitution of glyphosate for any of these glycines can be pre-
dicted to also promote protein aggregation.
         A seminal paper analyzed SOD1 for 150 missense muta-
tions, and showed that, overall, the mutations led to a highly 
significant decrease in net charge and an increased tendency to 
aggregate[50]. The degree of change in stability and net charge 
were inversely correlated with ALS patient survival times. The 
author uses the term “proteome exhaustion” to describe his pro-
posed theory for the underlying pathology linked to disease. The 
requirement for a high turnover rate to replace misfolded SOD1 
molecules places a high energy demand on an otherwise already 
high-energy demand cell type: the motor neuron. This author 
wrote: “This analysis shows that protein misfolding diseases 
such as ALS are not necessarily caused by specific molecular 
toxicity of misfolded protein species, but possibly by system-
ic exhaustion due to elevated protein turnover. This mechanism 
could explain why identification of such malicious protein states 
has so far been unsuccessful.” Glyphosate substitution for gly-
cine in any of the conserved glycines in SOD1 would lead to 
both an increase in negative charge and an increased tendency to 
aggregate. This could explain how even wild type SOD1 can be 
linked to ALS pathology[51,52].
      Intriguingly, both TDP-43 and FUS are members of a broad 
class of proteins known as “RNA binding proteins.”[53]. FUS is 
involved in activation of translation from RNA to protein syn-
thesis[54]. TDP-43 maintains protein quality control, and it re-
sponds to protein folding stress and regulates the levels of mis-
folded proteins[55]. Optineurin is another RNA binding protein, 
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and it too has been linked to ALS[56]. Impaired optineurin func-
tion leads to progressive demyelination and axonal degenera-
tion through receptor-interacting kinase 1 (RIPK1)-dependent 
signaling. RIPK1 activation is also induced by mutant SOD1[56]. 
Oligodendrocytes in particular are targeted, and impaired opti-
neurin leads to impaired supply of myelin to the myelin sheath 
by oligodendrocytes.
 RNA binding proteins respond to stress by inducing 
protein aggregation together with messenger RNA into “stress 
granules” (SGs) in a normally reversible process[53]. SGs in the 
cytoplasm are highly involved with RNA metabolism and ho-
meostasis[53,57-59]. They are believed to function by accumulating 
at a site of specific cellular stressors such as alterations in ho-
meostasis and temperature, external sources such as exposure 
to infection and chemicals as well as to internal sources such as 
mitochondrial and oxidative stress. Once thought to serve a role 
in the pathological process, it is now recognized that SGs func-
tion as a physiological process in a protective role. RNA-bind-
ing proteins recruit target mRNAs and round them up into SGs, 
which are then disassembled once cellular stress subsides[60]. 
This may be a way to temporarily halt synthesis of selected pro-
teins. However, evidence points to pathological ALS proteins 
having the ability to dramatically disrupt SG function, thereby 
perpetuating further neuronal loss. In ALS, and in many other 
neurological diseases, accumulation of stress granules as protein 
inclusion bodies eventually disrupts cellular function.
           It is striking that RNA binding proteins aggregate specif-
ically through their glycine rich domains[53,61]. There is a 10-gly-
cine stretch from amino acid residue 222 to 231 in exon 6 of 
FUS, and multiple cases of fALS are associated with deletions 
of several of those glycines[62]. The glycine-rich C-terminal re-
gion of TDP-43 is particularly aggregation prone. As shown in 
Figure 1, multiple missense mutations in this glycine-rich region 
have been linked to ALS[63]. Both of these proteins can be ex-
pected to be upregulated in response to the misfolding of SOD1. 
Cytotoxic granule associated RNA binding protein (TIA-1) is 
another RNA binding protein with a glycine-rich region[53].
         It appears that there is evolutionary pressure to replace 
G93 in SOD1 with an alternative amino acid. Provocatively, this 
could mean that environmental factors, such as the vulnerability 
of glycine to glyphosate disruption, can influence mutation rates. 
Thus far, six distinct amino acid substitutions have been seen: 
serine, valine, asparagine, alanine, cysteine and arginine[64]. 
Interestingly, a common mutation, G93S, has a more virulent 
phenotype in the offspring compared to the parents. Averaged 
over nine parent-offspring pairs, the mean age of onset was 64.4 
years in the parents, compared to 44.8 years in the offspring. An 
increase in a synergistic environmental factor such as glyphosate 
could explain this observation.
        The short-chain dehydrogenase/reductase (SDR) super 
family represents one of the largest protein super families known 
to date. These enzymes catalyse nicotinamide adenine dinucle-
otide (P)(H)-(NAD(P)(H)-) dependent reactions, and their sub-
strates are diverse, including polyols, retinoids, steroids, fatty 
acid derivatives and xenobiotics[65]. There are at least 73 mem-
bers of this family in the human genome. They share a highly 
conserved glycine-rich structural motif, Gx(x)GxxG, with the 
NADH:ubiquinone oxidative reductive subunit of Complex 
I[66,67]. A highly conserved GxGxxG motif is found in NAD(P)
H:quinone oxidoreductases from a variety of species[68]. This 
motif seems fundamental because enzymes that are not descend-
ed from a common ancestor share the motif. Patients with ALS 
have been shown to have impaired Complex I activity in their 
lymphocytes[69].
           The hexosamine biosynthetic pathway begins with fruc-
tose-6-phosphate and glutamine as substrates, and the end prod-
uct is uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) 
a nucleotide sugar that is a precursor to many other derivative 
sugars that are incorporated into the heparan sulfate and chon-
droitin sulfate chains in glycosylated proteins.
Figure 1: The multiple ALS-linked genetic variants of TDP-43 are con-
centrated in the C-terminal glycine-rich region. NLS: nuclear localiza-
tion signal; NES: nuclear export signal; RRM: RNA recognition motif. 
Figure adapted from Lagier-Tourenne et al.[48]
 Many of the enzymes that produce these derivative sug-
ars, such as fucose and xylose, are NADPH-dependent members 
of the SDR family, and therefore they possess the Gx(x)GxxG 
motif that is essential for NADPH binding[70]. A G20A mutation 
in the GxxGxxG motif of FloA1, a UDP-GlcNac dehydratase 
in Helicobacter pylori, resulted in a complete loss of activity, 
suggesting that structural alterations of the nucleotide-binding 
site were involved[71]. A study on chondroitin sulfate chains in 
sea cucumbers showed that fucose branches induce resistance to 
degradation[72]. Deficiencies in these enzymes could lead to not 
only impairment in the ability to maintain the gut mucosal lining 
but also an accumulation of excess amounts of unmetabolized 
fructose-6-phosphate and glutamine.
        More generally, the GxxG motif is important for stabiliz-
ing binding to both FAD and NAD(P) in oxidoreductases that 
are members of this broad but important class of enzymes[70]. 
Both UDP-GlcNAc and its derivatives, fucose and xylose, are 
essential constituents of glycosaminoglycans, proteoglycans, 
and glycolipids[73]. An important member of the SDR family is 
UDP-xylose synthase (UXS), also known as UDP-glucuronic 
acid (UDP-GlcA) decarboxylase and UDP-GlcA carboxylase, 
which catalyzes decarboxylation of UDP-glucuronic acid to 
produce UDP-xylose[74,75]. Xylosyl transferases are enzymes 
that catalyze the transfer of xylose from UDP-xylose to selected 
serine residues in the proteoglycan core protein[76]. This is the 
initial and rate-limiting step in mammalian glycosaminoglycans 
synthesis. Thus, a steady supply of UDP-xylose is absolutely es-
sential for maintaining a healthy mucosal lining in the gut.
 Not only are both xylose synthesis and xylose trans-
port dependent upon essential glycine residues, but also the 
glyosylated protein’s attachment site for xylose is often glycine 
enriched. While the attachment site for the xylose sugar that ini-
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tiates the synthesis of a chondroitin sulfate or heparan sulfate 
chain is a serine residue, this residue is always embedded in a 
short peptide sequence that is highly enriched in glycine resi-
dues[77]. The best acceptor protein known for xylosyl transferase 
is the alpha-trypsin inhibitor, bikunin. The chondroitin sulfate 
attachment site in this case includes a conserved glycine resi-
due before the serine residue and a sequence of three glycine 
residues after the serine residue. A comparison of 50 different 
proteoglycans revealed a consistent pattern of a-a-a-a-Gly-Ser-
Gly-a-Gly, where ‘a’ stands for any acidic amino acid. Thus, it 
can be expected that glyphosate substitution for any of these gly-
cine residues would disrupt the attachment of xylose and there-
fore the initiation of synthesis of chondroitin sulfate or heparan 
sulfate. This is likely to be highly disruptive of the maintenance 
of the mucosal lining in the gut.
            Transporter proteins involved in the synthesis of proteo-
glycans are also likely to be disrupted by glyphosate. There are 
several distinct transporters for the various nucleotide sugars in-
volved in proteoglycan synthesis, and they belong to the protein 
class, SLC35[78,79]. Mammalian cells in the gut could be impaired 
in their ability to import fucose and xylose into the Golgi appara-
tus due to disruption of the glycines in these transporters through 
glyphosate exposure.
          The GDP-fucose transporter SLC351 critically regulates 
the fucosylation of glycans[80], and defective versions are linked 
to serious disorders[78]. Three highly conserved glycine residues, 
Gly180, Gly198, and Gly277, in transmembrane helices 5, 6 and 
8 of this transporter play essential roles in its activity. A substi-
tution of tyrosine for Gly180 significantly diminished protein 
activity, and isoleucine substitution for Gly277 completely abol-
ished all cell surface fucosylation. It is interesting to note that 
glyphosate upregulates the expression (by at least a factor of 2) 
of four enzymes involved in fucose metabolism in E. coli: L-fuc-
ulose-1-phosphate aldolase, L-fucose isomerase, L-fuculokinase 
and fucose permease[81]. This may reflect a suppressed ability to 
incorporate fucose into branching glycans.
       ALS patients have a deficiency in the serum levels of 
T-cell-expressed immunoglobulin Gs (IgGs), which are high-
ly glycosylated proteins[82]. More specifically, the serum levels 
of fucosylated glycans in IgG N-glycans in ALS patients were 
found to be significantly reduced relative to the levels of si-
alylated glycans[83]. Under-fucosylated IgGs are also expressed 
in the motor cortex of ALS patients. A distinct fucose-deficient 
glycan, A2BG2, derived from ALS patient sera, enhances anti-
body-dependent cellular toxicity, and leads to over expression 
of CD16 and activated microglia in G93A-SOD1 mice[82]. Not 
only is A2BG2 specific for ALS, but also the amount produced 
is correlated with disease progression[84]. An active area of can-
cer drug research involves producing specific antibodies to pro-
teins that tumor cells critically depend upon for survival. Special 
techniques have been developed to produce severely under-fu-
cosylated antibodies in order to increase their toxicity to tumor 
cells[85]. Lack of core fucosylation in IgG results in a 50- to 100-
fold increase in antibody-dependent cellular cytotoxicity[86]. It 
can therefore be predicted that under-fucosylated antibodies 
produced by ALS patients would be especially virulent in auto-
immune disease.
        Cytochrome c oxidase (CcO), also known as complex 
IV, is the last enzyme in the respiratory electron transport chain. 
Decreased CcO activity has been detected in the spinal cords 
of ALS patients[10,11]. CcO operates as both an enzyme catalyz-
ing the reduction of oxygen to water and as a transmembrane 
proton pump. The segment that gates the protons overlaps the 
channel through which oxygen is delivered to the catalytic site. 
Replacement of a single glycine in a narrow part of this channel 
with valine completely blocks oxygen access to the catalytic site 
and results in the formation of a compartment around the site 
that is impermeable to small gas molecules. The catastrophic re-
sult is that it binds O2 several orders of magnitude more slowly 
than wild-type CcO[87]. This can be predicted to lead to leakage 
of superoxide and oxidative damage to neighboring vulnerable 
molecules.
Figure 2: Schematic of metabolic pathways involving fructose and 
their disruption by glyphosate, leading to disease. PEP: phosphoenolpy-
ruvate. Fructose 6 P: Fructose 6 phosphate. Glucosamine 6 P: glucos-
amine 6 phosphate.
Table 2: Amino acids paired with glycine in the dipeptide sequences 
synthesized from poly- GGGGCC, and their associated non-coding an-
alogues. The CAG CAG repeat linked to Huntington’s disease is also 
included in the table, for completeness. Aze: Azetidine-2-carboxylic 
acid. DON: 6-Diazo-5-oxo-L-norleucine.
Pattern Paired Amino Acid Analogue  Reference
GGG GCC Gly-Ala L-alanine R S Roy et al. [212]
GGG CCG Gly-Pro Aze K K Bessonov et al. [213]
GGC CGG Gly-Arg L-canavanine  J Krakauer et al. [214]
CAG CAG Gln-Gln DON CC Clark et al. [215]
Metabolic Disturbances
Gut Dysbiosis
 ALS is a debilitating disease with high morbidity and 
very poor treatment prognosis. Therefore, finding the early fac-
tors that eventually lead to the development of ALS seems like 
the best pathway towards conquering this disease. Thus, research 
efforts should be redirected towards uncovering the metabolic 
pathologies that precede overt expression of ALS symptoms. As 
schematized in Figure 2, we hypothesize that two important risk 
factors for ALS are excess dietary fructose from processed foods 
and chronic glyphosate exposure. As evidenced by the seminal 
paper on mutant SOD1 mice[6], the disease process likely begins 
in the gut. An imbalance in gut microbial distributions, partic-
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ularly a deficiency in butyrate-producing species in the colon, 
leads to increased intestinal permeability and liver stress, like-
ly due in part to impaired microbial clearance of fructose. The 
burden of fructose metabolism then falls primarily on the liver, 
which leads directly to hepatic steatosis. As the liver begins to 
fail, more fructose breaks past the hepatic barrier to enter the gen-
eral circulation. As a consequence, skeletal muscles succumb to 
excess exposure to fructose and its highly glycating derivatives 
like methylglyoxal[88]. Over time, the skeletal muscles suffer in-
creasing damage, in particular through concurrent exposure to 
glyphosate that puts an increased burden on the motor neurons 
to produce sufficient excitatory stimuli through neurotransmitter 
release. Eventually, the motor neurons suffer widespread dam-
age and the overt symptoms of ALS become manifest. Mineral 
imbalances accelerate the decline.
        The colonic environment is largely anaerobic, and the 
normal flora thrive by fermenting luminal complex carbohy-
drates derived from food sources or from the mucins produced 
by human goblet cells[89,90]. The colonic flora produce short chain 
fatty acids (SCFAs), including butyrate, succinate and propio-
nate, and these are an important energy source for the colonic 
epithelial cells. Butyrate in particular has remarkable beneficial 
biological effects including histone deacetylase activity[91], and 
protection from colitis and colon cancer[90].
          Butyrate producing bacteria are reduced long before 
overt ALS symptoms appear in an ALS mouse model[6]. N-ace-
tyl tryptophan has shown therapeutic promise in a mouse mod-
el of ALS[92]. Tryptophan is a precursor for the quorum-sensing 
molecule indole, which mediates intercellular signaling among 
bacteria. Indole enhances barrier function of intestinal epithelial 
cells, by inducing the expression of genes responsible for tight 
junctions, adherens junctions, the actin cytoskeleton and mucin 
production[93,94]. In 2015, Parker proposed that glyphosate could 
induce impaired intestinal permeability in part through the re-
duction in supply of tryptophan as a consequence of its disrup-
tion of the shikimate pathway[95].
          When the infant first adopts solid food, the intestine under-
goes a profound transformation that involves a rapid growth of 
Bacteroides thetaiotaomicron, a species that is highly skilled in 
breaking down complex carbohydrates[96]. This species, in turn, 
induces the synthesis of fucosylated and sulfated glycans (mu-
cins) by intestinal goblet cells. Bacteriodes species are adept at 
detaching these mucins from the intestinal wall and supplying 
them as a source of nutrition to other commensals, in addition 
to consuming them themselves. This symbiotic relationship be-
tween host and commensals leads to a healthy microbial distri-
bution throughout life. Experiments with germ-free mice have 
shown that fucosylated glycan expression after weaning depends 
on the colonization by B. thetaiotaomicron[97]. B. thetaiotaomi-
cron in particular is a dominating bacterium in the distal human 
gastrointestinal tract and plays a significant role to supply ace-
tate to the butyrate-synthesizing microbes[98].
 Bacteroides species are the most abundant gram-nega-
tive bacteria in the human gut, reaching a density of more than 
1010 bacteria per gram of feces[99]. They have a tremendous ca-
pacity to degrade polysaccharides from both plants and the host 
organism. B.thetaiotaomicron, and, in fact, nearly all Bacteroi-
des species, have two highly conserved and distinctly different 
forms of UDP-xylose synthase[100]. It has presented a puzzle to 
researchers as to why they synthesize UDP-xylose, because it is 
unclear what they use it for. Xylose is notably absent in bacterial 
cell walls, and they do not possess a xylosyltransferase enzyme.
          We propose that their main purpose is to supply this im-
portant nutrient to the host to initiate glycosylation of membrane 
proteins so that the host can maintain a healthy mucosal environ-
ment for the bacterium. Significantly, mammalian cells secrete 
xylosyltransferase into the medium - the enzyme that attaches 
xylose to a serine residue in a glycoprotein. This fact also pre-
sented a puzzle to the researchers who investigated this, because 
the mammalian cell culture did not export any xylose to supply 
to the enzyme. We hypothesize that B. thetaiotaomicron and the 
host mucosal cells collaborate to produce the thick mucin walls 
of the colon.
        An interesting recent study provides significant insight 
into how an important commensal microbe such as B. thetaio-
taomicron is able to protect itself from immune attack induced 
by an inflammatory response to pathogens in the gut[101]. B. the-
taiotaomicron resists binding to cationic antimicrobial peptides 
produced by the host immune cells through the activities of a 
lipid-A phosphatase enzyme that reduces the negative charge in 
the microbe’s outer wall by detaching phosphate groups from 
lipid-A. This phosphatase enzyme is a member of a broad class 
of lipid phosphatases that contain a highly conserved sequence 
of four peptides: PSGH[102]. While the significance of this pep-
tide sequence to function is not yet clear, it can be predicted that 
substituting glyphosate for the glycine residue would likely dis-
turb the enzyme’s behavior, and could lead to a reduction in B. 
thetaiotaomicron populations in the gut following an inflamma-
tory response. Glyphosate has been patented as an antimicrobial 
agent, and it negatively impacts a large number of microbial spe-
cies resident in the human gut[30]. The growth rate of Bacteroides 
in particular is severely reduced by glyphosate[103].
       While dietary fiber has not been found to be protective 
against ALS[104], it must be kept in mind that important sources 
of fiber such as wheat, oats, barley, and legumes, are likely to 
be highly contaminated with glyphosate, due to the widespread 
practice of spraying these crops with glyphosate shortly before 
harvest as a desiccant[105]. Therefore, any potential benefits of the 
fiber may be offset by increased exposure to glyphosate.
Fructose Overload
 Adipose tissue is a major metabolizer of fructose, prob-
ably exceeded only by the liver and gut[106]. Mouse fibroblasts 
in the presence of fructose as the only carbohydrate readily dif-
ferentiate into adipocytes, suggesting that fructose is adipogen-
ic[107]. A person with a lean body frame has very little adipose tis-
sue, and therefore the ability to clear excess fructose through this 
pathway is severely restricted. Curiously, diabetes is protective 
against ALS, and this may follow from a reduced exposure of 
muscle cells to glycating sugars when insulin-based glucose up-
take is impaired[108]. Anecdotally, an Italian professional soccer 
player who supplemented routinely with fructose 1,6 bisphos-
phate developed early onset of the bulbar form of ALS at the age 
of 45 years[109].
            Glyphosate is frequently used as a ripener preharvest for 
sugar cane crops, and it increases the storage of sugars in the 
cane. It likely does this by impairing the synthesis of complex 
carbohydrates. A study on lupine plants showed that exposure to 
sublethal levels of glyphosate caused a decrease in starch content 
and an increase in sucrose[110]. The mechanism was attributed to 
inhibition of phosphoenol pyruvate carboxylase (PEPC), which 
is an important enzyme for the incorporation of both carbon and 
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nitrogen into organic matter.
          PEP is substrate to both PEPC and 5-enolpyruvylshikim-
ic-3-phosphate synthase (EPSPS), the enzyme that is disrupted 
in the shikimate pathway by glyphosate, leading to impaired 
synthesis of aromatic amino acids in plants and microbes. This 
is believed to be the main toxic effect of glyphosate to weeds. 
Both PEPC[111] and EPSPS[112,113] have essential glycines at the 
active site which, if replaced by glyphosate, would severely 
disrupt enzyme activity. This is probably the main explanation 
for its suppression of these enzymes. Changing the DNA code 
from glycine to alanine in E coli’s EPSPS completely abolishes 
glyphosate’s inhibiting effects[113]. Other microbes have acquired 
resistance through this same mechanism, and this is the basis 
for the bacterial gene modification in GMO Roundup-Ready 
crops[114].
            Replacement of the terminal glycine in E. coli PEPC 
with a negatively charged amino acid such as aspartate resulted 
in a complete shutdown of enzyme activity[111]. These authors 
wrote: “PEPC appears to not tolerate additional negative charge 
at its extreme C terminus beyond that of the main chain free CO2͞ 
group.” Glyphosate substitution for the terminal glycine adds 
negative charge: it adds a CH2PO3H- anion at the C terminus. We 
hypothesize that the accumulation of PEP due to its blockage as 
substrate in these two important pathways would result in the 
inhibition of the pathway that converts fructose to PEP, lead-
ing to an accumulation of fructose and forcing more fructose to 
be phosphorylated to fructose 1,6 bisphosphate and fed into the 
glycolysis pathway. This likely also means that much of the di-
etary fructose is left unmetabolized by the gut microbes, instead 
placing a large burden on the liver to metabolize fructose, and 
explaining the epidemic we are seeing in fructose-induced fatty 
liver disease[115-117].
Sulfur Dysbiosis
 Due to increased awareness of the benefits of butyrate 
to colonic health, a feeding study was conducted on rats to inves-
tigate the effect of different sources of protein and carbohydrate 
on butyrate production[118]. The rats were fed either fructooligo-
saccharide or a potato starch as carbohydrate, along with either 
casein or rice or soy as a protein source. An enhanced production 
of butyrate was associated with rice protein compared to casein 
or soy. We hypothesize that a factor in this observed difference 
was increased glyphosate contamination in the casein and soy, 
compared to rice. This is plausible given that most soy is en-
gineered to be glyphosate resistant and casein is derived from 
cows that are fed high doses of glyphosate in their feed. Further-
more, they found that a poly-methionine supplement corrected 
the low-butyrate yield for both casein and soy. A plausible hy-
pothesis is that glyphosate interfered with methionine synthesis, 
but supplementation compensated for this. Methionine, a sul-
fur-containing amino acid, is essential for maintaining adequate 
levels of the important antioxidant glutathione in the liver, as 
well as the sulfonated amino acid, taurine, which is a significant 
component of bile acids.
       A study on carrot cell lines showed that glyphosate reduced 
methionine levels by 50 to 65%[119]. A mechanism by which gly-
phosate could affect the synthesis of methionine by gut microbes 
is via glyphosate’s suppression of 3'-phosphoadenosine 5´-phos-
phosulfate (PAPS) reductase. A study on E. coli showed a 3.75 
fold reduction in activity in the presence of glyphosate[120]. This 
enzyme is the rate-limiting enzyme in methionine synthesis. A 
structural analysis of the active site of yeast PAPS reductase re-
vealed that it has three highly conserved motifs that collective-
ly contain four glycine residues: two glycines in the 3´-P loop 
(51GLTG54), a single glycine in the middle of the so-called Arg 
loop, and a single glycine in the C-terminal catalytic motif, EC-
GIH, all of which are crucial to the protein’s enzymatic func-
tion[121].
          A study on cows comparing a low-sulfur with a high-sulfur 
diet showed that sulfur was beneficial while the cows were graz-
ing on grass, but that excess sulfur became problematic, caus-
ing a reduction in weight gain, once they were in the finishing 
stage[122]. Presumably, they were switched to a diet consisting of 
genetically engineered corn and soy feed that was likely heavi-
ly contaminated with glyphosate. Steers receiving the high-sul-
fur diet had a significant increase (p = 0.03) in sulfur reducing 
bacteria in the rumen, particularly Desulfovibrio desulfuricans, 
following adoption of the finishing diet. The high-sulfur diet re-
sulted in a decrease in both butyrate and acetate compared to 
propionate, as well as an increase in the production of hydrogen 
sulfide gas. It is likely that glyphosate chelation of molybdenum 
contributes to this imbalance, as molybdenum catalyzes sulfite 
oxidase. Furthermore, copper suppresses the growth of Desulfo-
vibrio species[123], so copper chelation by glyphosate might pro-
mote their growth. Strains of Desulfovibrio can utilize fructose 
as an energy source to reduce sulfate to hydrogen sulfide gas[124].
        Sulfur dioxide, sulfite and carageenan (sulfated polysac-
charides extracted from seaweed) are commonly found in the 
modern Western diet[125]. High doses of these oxidized sulfur 
compounds, in conjunction with chronic glyphosate poisoning, 
can be expected to yield an overgrowth of sulfur-reducing bacte-
ria in the colon at the expense of methanogenic species, and this 
has been directly linked to ulcerative colitis[125]. In vitro stud-
ies on isolated human colonocytes demonstrated that hydrogen 
sulfide specifically inhibits butyrate metabolism but not glucose 
oxidation by these cells[126]. H2S is implicated in ALS damage 
to motor neurons[127]. High levels of H2S have been found in the 
spinal fluid of ALS patients and in the tissues of mice with the 
SOD1G93A mutation[127]. 
        One of the toxic effects of sulfite is to destroy thiamine, 
leading to a thiamine deficiency problem[128,129]. Thiamine defi-
ciency has only recently been suspected as a causative factor in 
ALS. Following the deaths of two patients exhibiting signs of 
thiamine deficiency, researchers reporting in a 2015 paper inves-
tigated a potential role for thiamine deficiency in 122 patients 
with ALS[130]. They found severe thiamine deficiency in 18% of 
the patients with mild deficiency in another 10% of the patients. 
It may be highly significant that microbial thiamine synthase 
shares with ubiquitin the unique highly conserved double gly-
cine repeat at the C-terminal end[46,131]. Remarkably, a paralytic 
disease that has afflicted multiple bird species in Northern Eu-
rope since the introduction of glyphosate in the early 1980’s has 
been clearly linked to thiamine deficiency[132].
Liver Disease and Fructose Metabolism
 Patients with ALS tend to have exceptionally low lev-
els of urate in their serum, and urate levels are inversely cor-
related with disease severity[133]. Urate is synthesized in the liv-
er through degradation of purines in parallel with triglyceride 
synthesis. The rate-limiting enzyme, xanthine oxidase, depends 
on molybdenum as a cofactor. We have seen earlier that molyb-
denum deficiency could account for the toxicity of sulfite in the 
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gut due to impaired sulfite oxidase activity. Defective xanthine 
oxidase could lead to an inability of the liver to metabolize fruc-
tose to fats, along with a decreased synthesis of urate.
              Surprisingly, several studies have shown that alco-
hol consumption is protective against ALS. A meta-analysis in-
volving 431,943 participants obtained an odds ratio of 0.57 for 
the association between alcohol consumption and ALS[134]. The 
mechanism remains unclear. This protection is not without cost, 
however, because alcohol severely stresses the liver, leading to 
steatohepatitis, liver fibrosis, and hepatic cancer. Interestingly, 
both fructose and alcohol increase both urate synthesis and tri-
glyceride production in the liver, leading to nonalcoholic and al-
coholic fatty liver disease, respectively[135]. However, they have 
opposite effects on the ratio of NAD+ to NADH, with fructose 
increasing it and alcohol decreasing it. Tryptophan (a product of 
the shikimate pathway) is an important precursor to NADH in 
the liver, but tryptophan is also converted into kynurenine and 
stored in macrophages invading an inflamed gut[136]. Both the 
suppression of the shikimate pathway and the induction of an 
inflammatory gut by glyphosate should therefore lead to an im-
paired supply of NADH to the liver, as discussed in Samsel and 
Seneff[30]. It is plausible that insufficient liver NADH prevents 
the liver from metabolizing fructose, but alcohol partially cor-
rects this problem by renewing the supply through reduction of 
NAD+ to NADH, while simultaneously promoting liver disease. 
There could also be a more direct benefit through the high ni-
acin content in beer, as a precursor to NAD. Alcohol will also 
promote synthesis of urate, both directly and indirectly through 
its positive effect on fructose metabolism in the liver. Urate is 
neuroprotective in part through its induction of the nuclear fac-
tor (erythroid-derived 2)-like-2 (Nrf2) signaling pathway in as-
trocytes[137].
         In addition to molybdenum deficiency, NADH deficiency 
and an imbalance in the ratio of NAD+ to NADH, overactivity 
of Desulfovibrio species in the colon could also contribute to 
impaired liver metabolism of fructose and other sugars. H2S is 
highly diffusible and can easily migrate from a source location 
to neighboring tissues. High levels of endogenous H2S produced 
in the gastrointestinal tract[138] would readily diffuse to the liv-
er. It has been shown experimentally that the liver can consume 
large quantities of H2S, decreasing the NAD+/NADH ratio but 
consuming much of the available oxygen[139]. It can be predicted, 
therefore, that high exposure of the liver to H2S will compromise 
its ability to utilize oxidative phosphorylation to dispose of sug-
ars arriving from the gut via the hepatic portal vein. In the case 
of a high fructose diet and poor fructose metabolism in the gut, 
this will pass the burden of fructose disposal mainly on to the 
skeletal muscle cells.
        Even if the liver can clear much of the fructose in the 
presymptomatic phase of ALS, it is all the while accumulating 
excessive fatty deposits and suffering from cumulative damage 
due to chronic fructose exposure. In a rat model, copper defi-
ciency enhanced the adverse effects of a high sucrose diet in the 
liver, leading to fatty liver disease, along with liver inflammation 
and fibrosis[140]. Eventually, liver disease will prevent the liver 
from further sustaining low serum levels of fructose. An inves-
tigation of liver function in a mutant SOD1G93A mouse mod-
el of ALS revealed a dramatic increase in the levels of natural 
killer T (NKT) cells in the liver, along with organ atrophy and 
the accumulation of stored fats. Even pre-symptomatic hepatic 
lymphocytes of these mice secreted significantly higher levels of 
cytokines when stimulated by an NKT ligand ex vivo[141].
Mineral Imbalances
 Since both SOD1 and CcO are copper-dependent, it 
seems plausible that copper deficiency or excess could play a 
role in ALS. SOD1 is dependent on binding to both copper (Cu) 
and zinc (Zn) to function. Thus, an imbalance in the bioavail-
ability of these essential minerals could lead to impairment. 
Remarkably, a strong case for both Cu deficiency[16,142-144] and 
Zn deficiency[145] as playing a pathological role in ALS has been 
made in the research literature.
            CcO and Cu,Zn SOD (SOD1) are the two major cop-
per-binding enzymes in humans. The copper chaperone for SOD, 
CCS, has a stronger affinity for Cu than the chaperones for CcO. 
In a double mutant mouse model involving both human SOD1 
and human CCS (G93AxCCS mutant mice), CCS over-expres-
sion allows more Cu to be diverted into SOD, exacerbating any 
Cu deficiency problem induced by overabundant human SOD1 
enzyme expression[142].
          The Cu ATPase ATP7A is an important Cu-regulating 
protein which regulates both Cu(I) absorption from the small 
intestine and transport of Cu between the Golgi compartments 
and the plasma membrane of individual cells[146-148]. Mutations 
in ATP7A cause Menkes disease, a fatal infantile-onset neuro-
degenerative copper disorder, characterized by impaired billiary 
transport of Cu and many associated systemic pathologies[149,150]. 
ATP7A contains a glycine-glycine kink in the second trans-
membrane domain that forms a platform to accept Cu from the 
Cu-binding domains, to be pumped across the channel to the 
other side[149]. Glyphosate substitution for either of these gly-
cines can be expected to disrupt this function.
         A remarkable paper studying copper homeostasis in a 
mouse model of ALS proposed that the high copy number of hu-
man SOD1 in these mice places a high demand for Cu, resulting 
in general Cu deficiency[16]. They demonstrated that G93AxCCS 
mice developed ALS much more rapidly than single mutant 
SOD1 mice. These mice die about eight times faster than those 
without human CCS. Cu distribution is determined by affinity 
gradients, and SOD has the strongest affinity for Cu[151]. It is 
hypothesized that over-expression of CCS impairs Cu import 
into mitochondria, depriving CcO of Cu and thereby disrupting 
Complex IV[143,144]. Indeed CcO activity was greatly reduced in 
the SODG93AxCCS mice[143]. Remarkably, these double-mutant 
mice survived much longer if they were supplemented with a 
Cu complex, CuATSM. While this gives hope for a therapy for 
ALS patients, caution is necessary because excess Cu intake can 
cause toxicity.
          Although we hear much from the research literature about 
the antioxidant tripeptide, glutathione, much less is written about 
a possibly equally important tripeptide, glycyl histidinyl-lysine 
(GHK), most often referred to as GHK-Cu due to its ability to 
carry Cu[152]. This Cu-chelating tripeptide plays an important 
role in delivering Cu to cells. Both of these tripeptides contain 
glycine, and one has to wonder about the consequences of gly-
phosate substitution for glycine in them. It can be predicted that 
a glyphosate-based version of GHK-Cu would bind Cu much 
more tightly, thus making it unavailable to SOD1and CcO.
         A fascinating paper by Trumbull and Beckman discusses the 
role for Zn deficiency in the disease process[145]. Their compel-
ling arguments show that Zn deficient wild type SOD1 is more 
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destructive in inducing peroxynitrite synthesis from NO and 
O2. They further argue that Cu occupying the Zn site is much 
more redox active than Cu in the Cu site. They suggest that the 
benefits observed with Cu chelators such as d-penicillamine[153] 
and CuATSM[16] may be mainly due to their ability to extract Cu 
from the Zn site. Some of the mutant forms of SOD1 in familial 
ALS patients have a greatly reduced affinity to Zn (by as much 
as 30-fold)[154]. While Crow et al. proposed that this leads to en-
hanced tyrosine nitrosylation, another possibility is increased 
contamination of the Zn site by Cu.
         Manganese (Mn) appears to be inappropriately distributed 
in association with ALS[155-157], generally showing up in excess. 
Manganism is a neurological condition known to be caused by 
excess Mn exposure among Mn smelters and miners and among 
welders[158], and it manifests as symptoms of both ALS and Par-
kinson’s disease. In a study by Kapaki et al.[155], Cu levels were 
found to be depleted in both the cerebrospinal fluid (CSF) and 
the serum in ALS patients compared to controls, whereas se-
rum Mn levels were elevated. In Kapaki et al[156], a postmortem 
study on Mn levels in spinal cords showed significantly higher 
concentrations of Mn, particularly in the anterior horn. Kihira 
et al[157] found similar concentrations of Mn overall in the spi-
nal column between ALS patients and controls, but there was an 
imbalance between the anterior horn and the posterior horn with 
excessive concentrations in the anterior horn in association with 
ALS. Roos et al[159] looked at Mn concentrations in the CSF and 
the blood, and found substantially higher Mn concentrations in 
the CSF in association with ALS (5.67 µg/L vs. 2.08 µg/L).
        These odd distributions suggest that Mn may be distribut-
ed to the spinal column and CSF via a route that preferentially 
follows nerve fibers rather than through the circulation in ALS 
patients. In Samsel and Seneff[22], a link between abnormal Mn 
distribution channels and Parkinson’s disease was attributed 
to glyphosate’s disruption of bile flow through impairment of 
liver cytochrome P450 (CYP) enzymes. Normally, the liver re-
distributes Mn to the body through binding to bile acids. When 
this route is blocked, Mn is exported via the vagus nerve to first 
reach the brain stem nuclei and then spread from there, via nerve 
fibers, to other parts of the brain and spinal cord. Such pathways 
would explain both the high concentration in CSF and the excess 
Mn observed in the anterior horn, which is adjacent to the central 
canal in the spinal column. While we were unable to find any 
publications linking ALS directly to cholestasis, serum bilirubin 
levels are low in association with ALS[160] and tauroursodeoxy-
cholic acid, a major component of bile acids derived from tau-
rine, has shown promise as a treatment for ALS[161]. A pattern is 
thus emerging suggesting that an excess availability of Mn in the 
spinal column combined with deficiencies in Cu and Zn could 
lead to an ALS pathology.
           There are substantial parallels in a theory for the pathology 
underlying bovine transmissible spongiform encephalopathy[162]. 
In an environment that is Mn-rich with low bioavailability of Cu 
and Fe, excess Mn absorption combined with an oxidative en-
vironment induces Mn3+-initiated chain reactions which upreg-
ulate expression of the prion protein (PrP), a Cu-metalloprotein. 
Mn3+ substitutes for the vacated Cu domain on PrP, leading to 
PrP misfolding and resultant prion diseases. It seems plausible 
that a similar scenario could explain the accumulation of mis-
folded SOD1. The uniquely toxic peptide within prion protein 
has been identified as a short palindrome within a glycine-rich 
region, also known as the “hydrophobic core”[163]. The palin-
drome sequence is AGAAAAGA, and it is highly conserved 
across multiple species. It has been shown that excision of this 
sequence from the protein removes its toxic effects and its abil-
ity to effect prion propagation[164]. The glycines are specifically 
targeted as the toxic species within the sequence[165]. Glyphosate 
substitution for either of the glycines in the palindrome could 
explain the misfolding and the toxicity.
 Glyphosate is a potent metal chelator[166], and it is able 
to strongly bind to Mn[23], Zn[24] and Cu[25], making them unavail-
able to plants exposed to glyphosate[24]. Glyphosate will release 
these metals if the pH is sufficiently low. In the case of Cu, 
however, glyphosate does not release the metal ion until the pH 
drops to an extremely acidic level (pH 1.0)[167]. Thus, it can be 
predicted that glyphosate would behave much like other metal 
chelators in making both Cu and Zn unavailable to SOD1 and 
to CcO. When this is combined with the elevated Mn levels in 
the spinal column due to Mn’s distribution along nerve fibers, it 
paints a picture of severe mineral imbalances linking to ALS.
          More generally, the additional complexity of the presence 
of a strong metal chelator, which might be embedded within a 
peptide sequence, will make it much more difficult for the or-
ganism to properly manage metal distribution to the enzymes 
that depend on those metals. Glyphosate substitution for glycine 
in any of multiple glycine residues in SOD1 can be expected 
to strongly alter the binding capacity of SOD1 to metals. It can 
be predicted that glyphosate-substituted SOD1 would be much 
more reluctant to give up any bound metals. The possibility of 
such disruptions needs verification.
Progressive Neuromuscular System Failure
Muscle Failure
 Fructose has eight-fold higher reactivity as a glycat-
ing agent compared to glucose, and methylglyoxal, a product of 
fructose metabolism, is another order-of-magnitude more dam-
aging than fructose[168]. Many patients with ALS have a deranged 
muscle metabolism, with increased rates of muscle glucose up-
take and lactate output[169]. Fructose can be produced endoge-
nously through the aldose reductase (polyol) pathway. Skeletal 
muscle cells from patients with ALS show enhanced metabolism 
of glucose to fructose via the polyol pathway[170]. 
           Evidence also showed further fructose metabolism in the 
skeletal muscles via a fructolytic pathway involving aldolase[169], 
whose activity is linked to excessive production of the highly 
glycating agent, methylglyoxal[171]. A 2013 study by Dhar et al. 
showed that rats fed a diet high in fructose (60% of total calo-
ries) exhibited elevated levels of methylglyoxal in the aorta and 
kidney, along with hypertension and reduction in the antioxidant 
glutathione[172].
           Fast twitch muscles are contrasted with slow twitch mus-
cles in that fast twitch muscles have many more of the type-II 
fibers that make much greater use of glycolysis rather than oxi-
dative phosphorylation in their metabolism of sugars. This also 
means that they can process a great deal more fructose and me-
tabolize it to lactate, to be exported for distribution to other cells. 
But this also implies that they are more likely to be subjected 
to glycation damage from fructose and its derivatives such as 
methylglyoxal.
         In a mouse model, fast twitch muscles in particular pro-
duced a decreased level of force in response to calcium activa-
tion during end-stage ALS[173]. Another study on muscle strength 
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in a mouse model of ALS revealed that, presymptomatically, 
the contractile force of fast-twitch medial gastrocnemius (MG) 
muscles declined significantly[174]. While ALS related symptoms 
only appear at 90 days, already at the age of 40 days the mu-
tant SOD1 mice suffered from a 35% reduction in contractile 
strength in MG. While there was a concurrent reduction in the 
number of motor units, this reduction was of a significantly less-
er degree. By this time, the slow-twitch soleus muscle had suf-
fered from minimal decline.
        This effect can be explained by the steadily increasing 
uptake of glyphosate into myosin. Myosin is an ATP-dependent 
motor protein responsible for actin-based motility in muscles. 
A seminal study on a mutation in myosin involving the substi-
tution of alanine for glycine at G699 revealed that this single 
small change resulted in a reduction of motility of this molecular 
motor protein by 99%[175]! In the study, the authors were able to 
manipulate the percentage of myosin motors that were affected 
by this G699A substitution. They found that, with only 2% of 
the motors modified, there was a 50% reduction in overall motile 
force, because the defective 2% disrupted the movement of the 
healthy 98% by essentially getting in the way.
         Myosin is not the only molecular motor that essentially de-
pends on glycine. Kinesins and dyneins are extremely important 
in the long axons that connect motor neurons in the spinal col-
umn to the synapse of muscle cells in the skeletal muscles. Ki-
nesins in motor neurons transport mitochondria from the soma 
along the long axon to the synapse, and dynein transports spent 
mitochondria back to the soma. Both kinesin[176] and dynein[177] 
have highly conserved glycines that are essential for their proper 
function as motors. Dynein controls the return of damaged mi-
tochondrial to the soma for disposal through lysosomal process-
ing. A study on the toxic effects of the natural pesticide rotenone 
on neurons demonstrated that it disrupted axonal transport of 
mitochondria, in part by inhibiting the expression of dynein, and 
that this effect preceded impairment of neurotransmission[178]. 
Dynactin is a multiprotein complex that increases the efficiency 
of the dynein motor. A mutation in glycine at residue 59 in a 
dynactin subunit produces a familiar form of ALS with slow pro-
gression[179,180]. Transgenic mice expressing G59S in this subunit 
develop motor neuron abnormalities and degeneration[181-183].
         An association has been found between statin drug usage 
and ALS or an “ALS-like syndrome.”[184]. It is well established 
that a common side effect of statin drugs is muscle damage, 
and fast twitch muscles are affected preferentially[185]. Statin 
users, even without overt symptoms, have been found to have 
abnormally high ratios of serum lactate to pyruvate[186]. Elevat-
ed serum lactate is also associated with ALS, particularly under 
non-resting conditions[187]. It can be expected that statins would 
impair the liver’s ability to metabolize fructose, because of an 
impaired ability to synthesize sufficient cholesterol to buffer the 
fatty acids derived from the fructose. Studies have shown that 
mutant SOD1G93A mice exhibit hypercholesterolemia even be-
fore they express overt symptoms of ALS[188].
Glutamate Excitotoxicity in Synapses
 To understand the flexible control of motor neuronal 
impulses, researchers have especially focused on synapses, 
where chemical signaling via receptor ion channels replaces the 
high speed nerve impulse propagation by the axon. At axon ends, 
neurotransmitters are briefly generated, to stimulate or depress 
new impulses generated in the post-synaptic neuron for the next 
relay step. The amino acid L-glutamate is the most common ex-
citatory neurotransmitter in the central nervous system. Both the 
physical dimensions and chemical integrity of each synapse are 
maintained by astrocytes, glial cells which tightly wrap around 
each synapse, and which can quickly uptake glutamate to clear 
it from the synapse. After uptake, glutamate in the astrocyte is 
either converted into glutamine and later recycled back to the 
pre-synaptic nerve endings to be converted back to glutamate for 
recycling or introduced to the Krebs cycle as a source of cellular 
energy[189].
 Much recent ALS research has concentrated on clar-
ifying exactly these processes, as too much glutamate acting 
on the N-methyl-D-Aspartate (NMDA) receptors in particular 
is thought to contribute to stressing through calcium overload, 
destroying overactivated motor neurons[190]. Excessive Ca2+ in-
flow is known to stress the mitochondria, which, via oxidative 
metabolism, can generate excessive toxic superoxide and oth-
er ROS, challenging the SOD and other protective systems and 
potentially leading to mitochondrial membrane failure and cell 
apoptosis[189-191]. This overreaction is believed to play a role in 
initiating ALS neuronal degeneration. Glycine is also an agonist 
in NMDA receptors, and increased glycine concentrations can 
markedly increase NMDA-receptor-mediated excitatory post-
synaptic currents in hippocampal neurons[192]. Treatment with 
memantine, a low-affinity, non-competitive NMDA receptor 
antagonist, has shown promising results in the ALS mouse mod-
el[193,194].
              An important study by Cattani et al. on the effects of 
glyphosate exposure on hippocampal neurons in the rat brain, 
in vivo, showed several effects that relate directly to NMDA-in-
duced glutamate toxicity[191]. First, glyphosate increased the 
amount of glutamate released into the synapse, possibly by 
acting as a glycine analogue at the receptor site. Secondly, it 
reduced the astrocyte re-uptake of glutamate from the synapse, 
and the metabolic breakdown within the glial cell via glutamine 
synthetase. Finally, the ion current from Ca2+ into the post-syn-
aptic neuron was increased, adding to the oxidative load and en-
suing damage to mitochondria, i.e. excitotoxicity leading to neu-
ron death. Both NMDA receptors and L-type voltage-dependent 
Ca2+ channels (L-VDCC) responded to glyphosate to induce 
calcium overload. The inhibitory effect on glutamine synthetase 
in astrocytes observed in the Cattani study[191] is directly attrib-
utable to manganese chelation by glyphosate[22], as manganese 
catalyzes glutamine synthetase. Glyphosate also reduced levels 
of the important antioxidant glutathione and increased thiobar-
bituric acid reactive species (TBARS) characterizing oxidative 
damage. It is highly probable that such cumulative damage in 
brain and spinal cord motor neurons would be indistinguishable 
from ALS from other origins.
LPS, sALS and Protein Disruption
 In a study conducted in 2012 on poultry microbiota, it 
was found that glyphosate at a minimal inhibitory concentration 
(MIC) of Roundup was enough to disrupt microbiome balance 
through a number of mechanisms[103]. The study clearly demon-
strated that highly pathogenic bacteria were highly resistant to 
glyphosate, while beneficial bacteria were particularly suscep-
tible to its effects. Moreover, it was discussed that glyphosate 
impacted bacterial balance indirectly via its chelation effects on 
several minerals, including calcium, magnesium, manganese 
and iron. Bacteria require intercellular homeostatic balance of 
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metal ions for survival. This change in microbiome balance in-
duced by glyphosate is critical. Lipopolysaccharides (LPS), or 
endotoxins as they are also known, are a major component of the 
outer membrane of gram-negative bacteria. The most virulent 
form of Lipid A, the component of LPS which elicits the toxic 
effect, is found in pathogenic bacteria such as Escherichia coli 
and Salmonella species, both of which are resistant to glypho-
sate with a MIC value of 5 mg/ml, versus a MIC value of 0.15, 
0.30 and .075 µg/ml for various beneficial bacteria. This high 
level of resistance to glyphosate would allow for proliferation of 
virulent gram negative strains. Invading pathogens are original-
ly detected by pattern recognition receptors (PRRs) which then 
initiate the innate immune response. Toll-like receptors (TLRs) 
are a group of PRRs that recognize a number of pathogens with 
TLR4 being the receptor that reacts to LPS[195]. LPS activation of 
TLR4 also requires comolecules MD2 and CD14[196].
           While TLR4 has been historically associated with patho-
gen recognition, Ahmed et al. recently demonstrated the funda-
mental involvement of its activation with neuroinflammation in 
response to brain injury and tissue damage events[197]. Relating 
to neurological disease, Liu and Bing studied the role of LPS in 
Parkinson’s disease and reported that it not only induces pro-
gressive dopaminergic neuron loss, but also leads to behavioral 
deficits in animal studies[198]. In 2009, Zhang et al. found the 
level of circulating LPS in patients with sALS to be statistically 
significantly higher than in controls. A statistically significant 
higher level was found even in patients with only moderate 
impairment, suggesting a role for LPS in the pathogenesis of 
ALS[199].
             A hallmark of ALS and frontotemporal lobar degener-
ation (FTLD) is the aggregation of ubiquitinated proteins, with 
TDP-43 being a significant component. Consistent with the 
observation of statistically higher levels of circulating LPS in 
sALS patients, LPS, the endotoxin resulting from a dysbiotic 
state of increased gram-negative bacteria, has also been shown 
to be involved in the disruption of key ALS proteins, specifically 
TDP-43 and the amino acid glutamate.
            According to studies by Correia[200], LPS-induced in-
flammation promotes both mislocation and aggregation of TDP-
43. Specifically they reported that LPS treatment increased 
the amount of TDP-43 protein in both microglia and astrocyte 
cultures, without corresponding increases at the mRNA levels. 
Moreover, LPS treatment of microglia and astrocytes enhanced 
the cytoplasmic mislocalization of TDP-43. In microglia, LPS 
exposure also led to the formation of cytoplasmic TDP-43 punc-
tate aggregates[200].
         The relevance of glutamate to ALS has been noted pre-
viously. LPS acts synergistically with glutamate, significantly 
increasing glutamate’s toxicity[201], so patients with higher cir-
culating LPS, as seen with sALS, would be at risk of increased 
glutamate toxicity.
Other Factors
Collagen in ALS
 Multiple studies have revealed that the collagen in ALS 
patients is abnormal[202-205]. Field et al. noted that collagen from 
the skin of ALS patients is defective, and proposed that BMAA 
substituting for L-serine during protein synthesis of collagen 
could be an explanation, at least for those cases attributed to 
BMAA exposure. These authors wrote: “We hypothesize that 
the abnormalities seen in sALS collagen may result from the 
misincorporation of BMAA and subsequent misfolding of the 
collagen protein.”[204]
         Twenty five percent of the body’s total protein mass is 
collagen, and 25% of the amino acid residues in collagen are 
glycine residues. Hence substitution of glyphosate for glycine 
during collagen synthesis can be expected to highly disrupt the 
structure of the collagen triple helix.
        A study by Ono et al. examined the quality of the collagen 
in the spinal column in ALS patients compared to patients with 
other neurological diseases and a control group with no neuro-
logical diseases[202]. They found that collagen bundles were more 
fragmented and widely separated, and the fibrils were randomly 
oriented in the spaces surrounding the capillaries in the ALS pa-
tients, but these pathologies were not observed in either control
group. The ALS patients also had significantly less collagen 
overall in the spinal cord (p < 0.001).
     Another study by Ono et al. on the glycosaminoglycans in 
the skin of ALS patients revealed anomalously high levels of 
the unsulfated glycosaminoglycan, hyaluronic acid[203]. This gly-
cosaminoglycan is unique in that it is synthesized in the plasma 
membrane rather than in the Golgi body, and therefore it would 
not be disrupted by impaired transport of nucleated sugars such 
as GDP-fucose into the Golgi body.
GGGGCC Repeat Expansion
 GGGGCC repeat expansion in the C9 or f72 gene is 
the most common genetic defect linked to familial ALS, and 
therefore a review paper on ALS would not be complete without 
discussing this phenomenon[206]. This feature is present in about 
40% of familial ALS patients and even 8 - 10% of sporadic 
ALS patients. While wild-type expression of this gene typically 
includes on the order of 30 repeats of this sequence, hundreds 
of copies of GGGGCC are found in many people with ALS. 
It is notable that the number of copies often grows over time 
in individual cells, particularly in neurons, and this occurs not 
through copy error during DNA replication but rather through 
gene expansion during repair of errors in single strand DNA. It is 
hypothesized therefore that oxidative stress induces expansion, 
during times when the gene is actively expressed such that a 
single strand of DNA is exposed. This repeat expansion is rem-
iniscent of the genetic defect tied to Huntington’s disease[207]. In 
Huntington’s, there is a runaway repeat of the trinucleotide se-
quence CAG[208]. This sequence codes for glutamine, and there-
fore the translation of this gene leads to the synthesis of long 
peptides of poly-glutamine, which are believed to be linked to 
the toxic effects. There are at least eight other neurodegenerative 
disorders that are associated with poly-CAG sequences in other 
proteins.
        Defects in the protein 8-oxoguanine glycosylase (OGG1) 
are likely the cause of the pathological expansion of CAG se-
quences[209]. Whether OGG1 is also responsible for expansion of 
the hexanucleotide GGGGCC is not yet clear. OGG1 is respon-
sible for repairing the most common defect that arises in DNA 
due to oxidation damage, which is the oxidation of guanine to 
8-oxoguanine. OGG1 excises the defective nucleotide from the 
single-strand DNA sequence, and then subsequently DNA poly-
merase fills in the missing guanine. However, due to complex 
mechanisms involving the formation of hairpin turns, the repair 
mechanism can inadvertently reinsert additional nucleotides as 
a duplicate copy of the local CAG sequence. Thus, excessive 
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oxidation and defective OGG1 can lead to a continued lengthen-
ing of the CAG repeat sequence over time. Excessive oxidation, 
in turn, could be due to superoxide leakage following impaired 
CcO activity in the mitochondria because of copper shortages 
and/or glyphosate substituting for its conserved glycine, as dis-
cussed previously[86].
 There is a conserved glycine at position 42 on the αA-
βB loop in the A domain of OGG1 that is essential for discrim-
ination between guanine and 8-oxoguanine[210]. Whether substi-
tution of glyphosate for this glycine could disrupt the enzyme’s 
function is of no doubt; but exactly how it might explain the 
ability to induce repeat expansion is not clear. However, OGG2, 
which also repairs 8-oxoguanine sites, is missing the conserved 
glycine and does not cause the pathological repeat phenome-
non[211].
        Despite the fact that a start codon is missing, the poly-hexa-
nucleotide sequence of GGGGCC actually translates successful-
ly into multiple poly-dipeptides, with three distinct frame shifts 
yielding three different dipeptide sequences, as illustrated in Ta-
ble 2. Each of these has alternating glycines with one of three 
other amino acids: alanine, proline, and arginine. These poly-
peptides actually aggregate and accumulate in plaque regions 
also containing TDP-43 and FUS. It may be significant that all 
three of these amino acids have naturally occurring analogues 
that cause disease, as explained in the associated references 
provided in the table[212-214]. It seems plausible that the process 
that incorporates these amino acids in high concentrations into 
peptides that are removed from circulation may be a strategy to 
try to expunge the offending analogues from the cytoplasm. Cer-
tainly the high incorporation rate of glycine into these polypep-
tides should help to remove glyphosate from the cell. The CAG 
sequence in Huntington’s disease produces poly-glutamine, and 
the non-coding amino acid 6-Diazo-5-oxo-L-norleucine (DON) 
is a naturally occurring analogue of glutamine[215].
ALS as an Autoimmune Disease
 ALS is increasingly recognized as an autoimmune dis-
ease[216]. Humoral immune responses against motor nerve termi-
nals initiate physiological changes that disrupt calcium homeo-
stasis in motor neurons. Eventually, this leads to apoptotic cell 
death. Auto-antibodies to multiple proteins related to neuronal 
function have been found in association with ALS, including 
Fas, neurofilaments, voltage-gated Ca2+ channels, gangliosides 
and the acetylcholine receptor[148,217-222]. Furthermore, other au-
toimmune diseases, such as asthma, celiac disease, early-onset 
diabetes, multiple sclerosis, myasthenia gravis, Sjögren’s syn-
drome, systemic lupus erythematosus, and ulcerative colitis, in-
crease risk for a future diagnosis of ALS[223].
        When muscle fibers are incubated with IgG from ALS 
patients, the peak of the Ca2+ current response is attenuated[224]. 
This is likely due to an antibody reaction with L-type volt-
age-gated calcium channels. As confirmation, a study testing 
antibody responses of L-type voltage-gated calcium channels 
from rabbit skeletal muscle found that 75% of 48 patients with 
ALS produced antibodies that reacted with this protein, whereas 
only 1 out of 25 normal subjects tested positive, and only 1 out 
of 35 control patients with other diseases tested positive for this 
reaction[222].
       The antibody, immunoglobulin G (IgG) is the most domi-
nant immunoglobulin in the body. Binding of IgG/antigen com-
plexes to cellular receptors triggers a cellular immune response. 
IgG is a glycosylated protein, and the attached glycans convey a 
complex signal based on modifications involving the addition of 
galactose, sialic acid, fucose, sulfate, and bisecting N-acetylglu-
cosamine (GlcNAc) residues. The degree to which cells respond 
to antigen signaling depends critically on the specific configura-
tion of these modifications.
            We previously mentioned that fucosylated glycans are un-
der-represented in ALS IgG[83]. A unique under-fucosylated gly-
can from ALS patients increases the affinity of IgG to CD16 on 
effector cells, enhancing antibody-dependent cellular cytotoxic-
ity (ADCC). ALS IgG localized in the synapse between brain 
microglia and neurons of G93A-SOD1 mice are likely involved 
in neuronal damage. In vitro studies on ventral spinal cord mo-
toneuron-neuroblastoma hybrid cells have shown that IgG from 
ALS patients kills these cells by inducing apoptosis[225].
         Reduced levels of galactosylation of oligosaccharides are 
linked to lupus erythematosus and rheumatoid arthritis[226,227]. 
This interferes with terminal sialylation which has anti-inflam-
matory properties[228]. The lack of core fucosylation observed in 
association with ALS leads to a greatly enhanced binding to the 
receptor (up to 100-fold), due to carbohydrate-carbohydrate in-
teraction between the antibody and the receptor that becomes 
possible once fucose is no longer present[229].
           Patients with several different neurodegenerative disor-
ders, including Alzheimer’s, Huntington’s disease, Parkinson’s 
disease, multiple sclerosis, and ALS, have a substantially lower 
overall risk of developing cancer[230]. It could be that afucosylat-
ed IgG mediates this effect, at least in the case of ALS. Curi-
ously, there is considerable excitement lately regarding a new 
cancer therapy that involves chemically removing fucose from 
IgG’s that are then administered to patients with cancer as a way 
to induce an aggressive immune attack on the tumor[231]. There 
should be some concern that these antitumor therapies could 
lead to an increased risk to ALS in the future.
              Myasthenia gravis is an autoimmune neuromuscular 
disease that causes muscle weakness and fatigue. It is usually 
caused by circulating antibodies to nicotinic acetylcholine re-
ceptors at the postsynaptic neuromuscular junction. Antibod-
ies against these receptors have also been found in association 
with ALS[221]. Intriguingly, Mohan et al. found that antibodies to 
acetylcholine receptors are also cross-reactive with the myosin 
heavy chain through molecular mimicry[232]. To us, this suggests 
the possibility that glyphosate substitution for glycine at posi-
tion 699 in myosin heavy chain, beyond its predicted devastating 
effect on muscular strength[175], induces an immune reaction to 
defective myosin protein, initially, that in turn becomes active 
against the acetylcholine receptors via molecular mimicry. If this 
is true, it represents an elegant way to shut down muscle activity 
due to the accumulation of defective myosin protein. Choliner-
gic antibody-induced synapse loss leads to hypometabolism[233], 
which is a strong feature of chronic fatigue syndrome[234]. By di-
rect contrast, hypermetabolism in the brain is linked to ALS[235].
 We hypothesize that impaired glycosylation patterns on 
both the antibodies and the receptors are involved in autoim-
mune diseases, and that these are due to glyphosate disruption of 
protein function during the synthesis of glycosylated peptides.
A Role for Epigenetics
 Epigenetics explains how transcriptional activity is al-
tered across many genes as well as numerous signaling path-
ways through post-transcriptional modifications of genes and 
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proteins. Environmental stressors such as diet, toxic exposures, 
pollutants, medications, life events, and mild traumatic brain in-
jury (mTBI) all have the capability to stimulate gene expression 
by chemically modifying DNA and their proteins without per-
manently altering the genetic code[236]. These stressors and envi-
ronmental exposures can induce epigenetic changes that are in 
turn able to signal a gene being turned on (gene transcription) or 
turned off (silencing). The dynamics of epigenetic changes, un-
like static gene mutations, can be reversed by targeting enzymes 
and their signaling pathways. Epigenetics can include a process 
by which the genome interacts with and, through changes in 
gene expression, adapts with the environment through signaling 
mechanisms. While most of these mechanisms have been dis-
covered during development, similar phenomena are now being 
discovered in adults as well[237-241].
 Additionally, alterations in epigenetics regulation have 
been linked to environmentally induced PD, making epigenetics 
a key factor in its pathogenesis[242]. Lam et al., (2016) showed 
that, in identical twins, a genetic predisposition to ALS does not 
guarantee contracting the disease. The study concluded that en-
vironmental or epigenetic factors played the primary role in the 
altering of inflammatory cytokine gene expression[243].
          Choi and Kim discovered in their twin study that no genetic 
factors made a contribution to their conclusions, highlighting the 
importance of epigenetics and the role it plays on phenotype[244]. 
It was further recognized that gene expression variation can be 
influenced by a wide disparity of environmental triggers. Fur-
thermore, these authors stated that the influence of environmen-
tal elements on the gene-epigenetic machinery can actually alter 
the transcriptional activity of adjacent genes and that “epigenetic 
mechanisms can allow an organism to respond to the environ-
ment through gene expression changes.”
           Jiang et al. referred to epigenetics as the “new frontier in 
neuroscience.”[245] These gene-environment interactions are con-
trolled by diverse signaling mechanisms and pathways, many 
of which have yet to be discovered. The role glyphosate has on 
numerous epigenetic pathways in the body needs to be further 
elucidated. These outcomes and epidemiological studies will 
provide invaluable information regarding the specific etiological 
factors involved in ALS. A full comprehensive understanding of 
how environmental triggers, such as glyphosate, influence gene 
activity will be key to developing medications and therapies to 
manipulate these epigenetic pathways and unlock the mysteries 
of these diseases.
Discussion
 ALS is a debilitating disease with high mortality risk. 
The complex interplay of multiple causative factors makes it dif-
ficult to specifically identify those most significant early factors 
that precede the symptomatic stage. Yet it is necessary to under-
stand these early metabolic derangements in order to work to-
wards prevention, as it is nearly impossible to stop disease pro-
gression once a diagnosis of ALS is made. As shown in Figure 
2, we propose that metabolic dysbiosis in the gut, particularly 
with respect to fructose metabolism by the gut microbes, sets 
the stage for subsequent skeletal muscle damage followed by 
damage to the motor neurons supplying those skeletal muscles. 
Fructose is a precursor to PEP which is a substrate for both the 
shikimate pathway and another microbial pathway that fixates 
carbon from CO2 via PEP carboxylase. Both of these pathways 
have been shown to be disturbed by glyphosate, and the mecha-
nism likely involves substitution for highly conserved glycines 
in the target enzymes.
          ALS develops relatively late in life. In our view, the 
disease process unfolds slowly over decades in roughly four 
distinct stages. In the earliest stage, the action is mainly in the 
gut. Impaired supply of fucose and xylose to the colonic mucosa 
along with reduced bioavailability of butyrate to the colonocytes 
leads to a thinning of the colonic mucins and impaired gut bar-
rier function. This allows the escape of multiple inflammatory 
agents, including glyphosate itself, as well as fructose, LPS and 
H2S. In the second stage, hepatic disease comes into play as the 
liver attempts to clear excessive fructose while suffering from 
critical deficiencies in NADH and toxic exposure to glyphosate, 
LPS and H2S. Once liver fibrosis and steatosis reach a critical 
stage, the liver can no longer reliably clear fructose from the 
circulation, leading to the third stage of the disease.
         Particularly in the context of a lean body type and a physi-
cally fit person, skeletal muscles will take up the task of fructose 
clearance, mainly by converting it to lactate, anaerobically. Fast-
twitch muscles are preferentially harmed because they favor 
glycolysis over oxidative phosphorylation. Muscle overexertion 
encourages glyphosate uptake through amino acid transporters, 
and glyphosate incorporation into myosin severely impedes con-
tractive capacity. This increases the requirement for excitatory 
stimuli, at the synapse with the controlling motor neuron, and 
ushers in the fourth and final stage of the disease.
          In the final stage, multiple derailments cripple the spinal 
motor neurons. Excess demand from impaired muscles leads to 
increased energy requirements and therefore also increased anti-
oxidant requirements. Both SOD1 and CcO contain critical gly-
cines that could be disrupted by glyphosate, leading to increased 
oxidative damage and irreversible protein aggregation into stress 
granules, orchestrated by RNA binding proteins that could also 
be disrupted by glyphosate substitution for glycine. Molecular 
motors involved in transporting mitochondria down the long 
axons and back would also be severely impaired. Glyphosate 
contamination in oligodendrocytes leads to impaired myelin 
supply to the axons. Autoantibodies to glyphosate-contaminated 
proteins that resist proteolysis contribute to the disease process. 
A die-back effect working back along the axon from a synapse 
due to excessive glutamate expression is also likely. Oxidatively 
damaged mitochondria become wedged in the axon due to an 
inability to transport them back to the cell soma for clearance. 
In addition, impaired supply of Cu and Zn due to glyphosate’s 
chelation effects also plays a role.
 Remarkably, the most common genetic marker for ALS 
involves the synthesis of various glycine-containing poly-di-
peptide sequences, from multiple frame-shift protein synthesis 
from the pathologically repeated DNA sequence, GGGGCC. 
Provocatively, this could be a strategy to trap and clear glypho-
sate through construction and sequestration of glyphosate-con-
taminated dipeptide sequences.
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Figure 3: Graphical overview of the multiple ways in which glyphosate exposure can contribute to the development of ALS.
 It appears that we can now paint a profile of a person 
who is at increased risk to developing ALS. Certainly any of the 
known genetic markers will increase risk. However, indepen-
dent of this, dietary choices may play an important role. We can 
predict that a diet that is high in fructose, particularly high fruc-
tose corn syrup derived from GMO Roundup-Ready corn, com-
bined with an elevated ratio of dietary manganese and sulfur to 
dietary copper, along with a processed food diet rich in sulfites 
and carageenan, a lean body type, abstinence from alcohol and 
an excessive emphasis on physical fitness, captures a high-risk 
profile. Agricultural workers, particularly those who work with 
glyphosate resistant crops, are particularly vulnerable. For those 
who are not environmentally exposed, a simple step to reduce 
risk is to switch to a 100% certified organic whole foods diet 
with a significant reduction in dietary fructose and sucrose.
Conclusions
 According to the World Health Organization, the World 
Bank and Harvard School of Public Health, neurodegenerative 
(NDG) diseases will become the 8th leading cause of disease 
burden in developing regions. In addition, NDG diseases will 
surpass cancer and become the second leading cause of death 
by mid-century[246]. NDG diseases are expected to surpass 70 
million in 2030 and rise to over 100 million in 2050[247]. NDG 
disease is clearly a health burden and to some degree, a health 
crisis in our society.
 In this paper, we have presented a mechanism by which 
chronic glyphosate exposure can plausibly lead to ALS, due to 
its properties of metal chelation, disruption of gut microbes, 
impairment of fructose metabolism, interference with the sup-
ply of important nutrients, especially aromatic amino acids and 
their derivatives, toxic effects on the liver, and, most important-
ly, its potential ability to substitute for glycine during protein 
synthesis. The multiple links between glyphosate and ALS are 
illustrated through the graphical overview illustrated in Figure 
3. We have shown how a cascade beginning with gut dysbiosis, 
progressing to liver disease, muscle failure, and, finally, wide-
spread damage to motor neurons in the spinal column, can lead 
to a diagnosis of ALS after several decades of chronic exposure 
to glyphosate. Other NDG diseases have considerable overlap 
with ALS in terms of the characteristic feature of misfolded pro-
teins accumulating in inclusion bodies in nervous tissues. We 
believe that glyphosate is a strong factor in the alarming rise in 
multiple NDGs well beyond ALS. Especially given the insidious 
and destructive effects that glyphosate can be expected to induce 
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through substitution for glycine during protein synthesis, reg-
ulatory agencies should seriously consider banning glyphosate 
usage to control weeds or for any other purpose.
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